In This Section

Program

Please Note: All session times for the 13th AACR-JCA Joint Conference: From Cancer Discovery Science to Therapeutic Innovation are U.S. Hawaii–Aleutian Daylight (HDT).

Saturday, February 1

Sunday, February 2

Monday, February 3

Tuesday, February 4

Wednesday, February 5

Saturday, February 1

Welcome and keynotes

6-7:30 p.m.

  • Hiroyuki Mano, National Cancer Center, Tokyo, Japan
  • Catherine J. Wu, Dana-Farber Cancer Institute, Boston, Massachusetts

Opening reception

7:30-9 p.m.

Sunday, February 2

Continental Breakfast and “networking Roundtables”

7-8 a.m.

Plenary Session 1: Advances in Cancer Genomics

8-9:30 a.m.

  • Yasuhiro Murakawa, Kyoto University, Kyoto, Japan,
  • Hiromichi Suzuki, National Cancer Center Japan, Kyoto, Japan
  • Andrew Futreal, The University of Texas MD Anderson Cancer Center, Houston, Texas

Break

9:30-10 a.m.

Plenary Session 2: Cancer Immune Interaction

10-11:30 a.m.

  • Hiroyoshi Nishikawa, Kyoto University, Kyoto, Japan
  • Elham Azizi, Columbia University, New York, New York
  • Livnat Jerby, Stanford University, Stanford, California

Free time

11:30 a.m.-4 p.m.

Plenary Session 3: Cancer Evolution and the Tumor Microenvironment

4-5:30 p.m.

  • Sheila A. Stewart, Washington University in St. Louis, St. Louis, Missouri
  • Nobuyuki Kakiuchi, Kyoto University, Kyoto, Japan
  • Yoku Hayakawa, The University of Tokyo, Tokyo, Japan

poster session a

5:30-7:30 p.m.

Monday, February 3

Continental Breakfast and “Networking Roundtables”

7-8 a.m.

Plenary Session 4: Genome Instability

8-9:30 a.m.

  • Ashok Venkitaraman, Cancer Science Institute of Singapore, Singapore
  • Ivana Bozic, University of Washington, Seattle, Washington
  • Alberto Ciccia, Columbia University, New York, New York

Break

9:30-10 a.m.

Plenary Session 5: Cancer Plasticity and Resistance

10-11:30 a.m.

  • Noriko Gotoh, Kanazawa University, Kanazawa, Japan
  • Laura D. Attardi, Stanford University, Stanford, California
  • Tuomas Tammela, Memorial Sloan Kettering, New York, New York

free time

11:30 a.m.-4 p.m.

Plenary Session 6: New Treatment Modalities

4-5:30 p.m.

  • Nathaneal S. Gray, Stanford University, Stanford, California
  • Mika Kamata-Sakurai, Chugai Pharmaceutical Co., Ltd., Tokyo, Japan
  • Pietro Genovese, Dana-Farber Cancer Institute, Massachusetts

Poster session B

5:30-7:30 p.m.

Tuesday, February 4

Continental Breakfast and “Networking Roundtables”

7-8 a.m.

Plenary Session 7: Cancer Metabolism

8-9:30 a.m.

  • Marcia C. Haigis, Harvard Medical School, Boston, Massachusetts
  • Kenji Chamoto, Kyoto University, Kyoto, Japan
  • Ana P. Da Silva Gomes, H. Lee Moffitt Cancer Center, Tampa, Florida

Break

9:30-10 a.m.

Plenary Session 8: Population Sciences

10-11:30 a.m.

  • Elizabeth A. Platz, Johns Hopkins University, Baltimore, Maryland
  • Tomotaka Ugai, Harvard Medical School, Boston, Massachusetts
  • Keitaro Matsuo, Aichi Cancer Center, Aichi, Japan

Free time

11:30 a.m.-4 p.m.

Plenary Session 9: Novel Clinical Trials Platforms

4-5:30 p.m.

  • Takashi Owa, Eisai Inc., Nutley, New Jersey
  • Naoya Harada, Daiichi Sankyo, Tokyo, Japan
  • Naoto Ueno, University of Hawaii Cancer Center, Honolulu, Hawaii

Poster Session C

5:30-7:30 p.m. 

Wednesday, February 5

Continental Breakfast and “Networking Roundtables”

7-8 a.m.

Plenary Session 10: Novel Roles of RNA in Cancer

8-9:30 a.m.     

  • Akiko Takahashi, Japanese Foundation for Cancer Research, Tokyo, Japan
  • Akihide Yoshimi, National Cancer Center Japan, Tokyo, Japan
  • Adrian R. Krainer, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York

Break

9:30-10 a.m.          

Plenary Session 11: Data Science

 10-11:30 a.m.  

  • Benjamin Haibe-Kains, University of Toronto, Toronto, Ontario, Canada
  • Jorge S. Reis-Filho, AstraZeneca, Gaithersburg, Maryland
  • Shumpei Ishikawa, University of Tokyo, Tokyo, Japan

free time

11:30 a.m.-4 p.m.

Plenary Session 12: Novel Immunotherapies

4-5:30 p.m.

  • Yuki Kagoya, Keio University School of Medicine, Tokyo, Japan
  • Aude G. Chapuis, Fred Hutchinson Cancer Center, Seattle, Washington
  • Todd A. Fehniger, Washington University in St. Louis, St. Louis, Missouri

Poster Session D

5:30-7:30 p.m.